|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 5 (September 1), 1999:
pp. 1755-1760
Mutation of the p53 Gene Is Not a Typical Feature of Hodgkin and
Reed-Sternberg Cells in Hodgkin's Disease
Manuel Montesinos-Rongen,
Axel Roers,
Ralf Küppers,
Klaus Rajewsky, and
Martin-Leo Hansmann
From the Institute for Genetics, University of Cologne, Cologne; and
the Institute for Pathology, University of Frankfurt, Frankfurt,
Germany.
Point mutations of the p53 tumor suppressor gene are a frequent
finding in human carcinomas and are thought to be an important oncogenic event. In non-Hodgkin lymphomas, p53 mutations occur in a
minor fraction of cases. However, conclusive data are still lacking for
Hodgkin's disease (HD) where the analysis meets technical problems.
The neoplastic tumor cell clone in HD is represented by the large
Hodgkin and Reed-Sternberg (HRS) cells, which account for only a
minority of all cells in the tumor tissue (often <1%). To identify
putative HRS cell-specific mutations, single HRS cells were
micromanipulated from frozen tissue sections of HD biopsy specimens.
Exons 4 to 8 of the p53 gene (in which more than 90% of p53 mutations
associated with human neoplasms occur) were amplified from these single
cells and sequenced. Mutations of p53 were not found in HRS cells of
any of 8 cases of HD analyzed. We conclude that mutation of the p53
gene is only rarely, if at all, involved in the pathogenesis of HD.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. Drakos, A. Thomaides, L. J. Medeiros, J. Li, V. Leventaki, M. Konopleva, M. Andreeff, and G. Z. Rassidakis
Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma
Clin. Cancer Res.,
June 1, 2007;
13(11):
3380 - 3387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Montalban, J. F. Garcia, V. Abraira, L. Gonzalez-Camacho, M. M. Morente, J. L. Bello, E. Conde, M. A. Cruz, R. Garcia-Sanz, J. Garcia-Larana, et al.
Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin's Lymphoma Study Group
J. Clin. Oncol.,
May 1, 2004;
22(9):
1664 - 1673.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood,
February 15, 2003;
101(4):
1220 - 1235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Garcia, F. I. Camacho, M. Morente, M. Fraga, C. Montalban, T. A. C. Bellas, A. Castano, A. Diez, T. Flores, C. Martin, et al.
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays
Blood,
January 15, 2003;
101(2):
681 - 689.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Maggio, A. van den Berg, D. de Jong, A. Diepstra, and S. Poppema
Low Frequency of FAS Mutations in Reed-Sternberg Cells of Hodgkin's Lymphoma
Am. J. Pathol.,
January 1, 2003;
162(1):
29 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. F. Dukers, C. J. L. M. Meijer, R. L. ten Berge, W. Vos, G. J. Ossenkoppele, and J. J. Oudejans
High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome
Blood,
June 17, 2002;
100(1):
36 - 42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Thomas, A. Kallenborn, C. Wickenhauser, J. L. Schultze, A. Draube, M. Vockerodt, D. Re, V. Diehl, and J. Wolf
Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells
Am. J. Pathol.,
April 1, 2002;
160(4):
1521 - 1528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S A Pileri, S Ascani, L Leoncini, E Sabattini, P L Zinzani, P P Piccaluga, A Pileri Jr, M Giunti, B Falini, G B Bolis, et al.
Hodgkin's lymphoma: the pathologist's viewpoint
J. Clin. Pathol.,
March 1, 2002;
55(3):
162 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Garcia, R. Villuendas, M. Sanchez-Beato, A. Sanchez-Aguilera, L. Sanchez, I. Prieto, and M. A. Piris
Nucleolar p14ARF Overexpression in Reed-Sternberg Cells in Hodgkin's Lymphoma : Absence of p14ARF/Hdm2 Complexes Is Associated with Expression of Alternatively Spliced Hdm2 Transcripts
Am. J. Pathol.,
February 1, 2002;
160(2):
569 - 578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Franke, I. Wlodarska, B. Maes, P. Vandenberghe, J. Delabie, A. Hagemeijer, and C. De Wolf-Peeters
Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances
Blood,
March 15, 2001;
97(6):
1845 - 1853.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Jungnickel, A. Staratschek-Jox, A. Brauninger, T. Spieker, J. Wolf, V. Diehl, M.-L. Hansmann, K. Rajewsky, and R. Kuppers
Clonal Deleterious Mutations in the I{kappa}B{alpha} Gene in the Malignant Cells in Hodgkin's Lymphoma
J. Exp. Med.,
January 17, 2000;
191(2):
395 - 402.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
